WeVote
Log In

Bill

Bill

HB 4834

CONTROLLED SUB-TESTOSTERONE

104th Regular Session Introduced by Jaime Andrade and 29 co-sponsors

Illinois bill classifies testosterone as a controlled substance, restricting prescriptions and adding regulatory oversight for medical and non-medical use.

Placed on Calendar Order of 3rd Reading May 18, 2026
0
WeVote Research Nonpartisan
Bill Summary · HB 4834

Legislative bill overview

HB 4834 proposes to classify testosterone as a controlled substance in Illinois, placing it under state drug scheduling regulations similar to other controlled substances. The bill would require prescriptions to meet stricter requirements and impose additional regulatory oversight on testosterone distribution and use.

Why is this important

This legislation would significantly impact medical practice for hormone replacement therapy (HRT), transgender healthcare, and treatment of testosterone deficiency in cisgender patients. The change could affect tens of thousands of Illinois residents currently using testosterone therapeutically and alter how healthcare providers prescribe this hormone.

Potential points of contention

  • Medical necessity vs. abuse prevention: Proponents argue controlled status prevents misuse in bodybuilding/performance enhancement; opponents contend legitimate medical patients would face access barriers and increased costs
  • Transgender healthcare implications: LGBTQ+ advocates worry restrictions could delay or deny transition-related care; supporters may frame it as protecting minors from experimental treatments
  • Prescriber burden: Healthcare providers express concerns about increased administrative requirements potentially discouraging treatment of hypogonadism and other legitimate conditions
  • Deviation from federal policy: Testosterone remains non-controlled federally under DEA scheduling, creating potential conflicts with federal law and interstate complications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.